Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

The number of new coronavirus cases and deaths reported globally continued to fall nearly everywhere in the world in what the World Health Organization described as a “welcome decline” at a media briefing on Wednesday.
The U.N. health agency said there were 4.5 million new COVID-19 cases reported last week, a 16% drop from the previous week. Deaths were also down by 13%, with about 13,500 fatalities. WHO said COVID-19 infections dropped everywhere in the world while deaths decreased everywhere except for Southeast Asia, where they climbed by 15% and in the Western Pacific, where they rose by 3%.
WHO Director-General Tedros Adhanom Ghebreyesus warned that with the coming onset of winter in the Northern Hemisphere and the possible emergence of a more dangerous new COVID-19 variant, experts expect to see a spike in hospitalizations and deaths. Tedros said vaccination rates, even in rich countries, were still too low, noting that 30% of health workers and 20% of older people remain unimmunized.
“These vaccination gaps pose a risk to all of us,” he said. “Please get vaccinated if you are not and a booster if it's recommended that you have one.” In the U.S., the Food and Drug Administration cleared its first update to COVID-19 vaccines on Wednesday, booster doses that target today's most common omicron strain. Authorities said shots could begin within days.
Until now, COVID-19 vaccines have targeted the original coronavirus strain, even as wildly different mutants emerged. The new U.S. boosters are combination, or “bivalent,” shots. They contain half that original vaccine recipe and half protection against the newest omicron versions, called BA.4 and BA.5, which are considered the most contagious yet.
Earlier this month, Britain decided it would offer adults 50 and over a different booster option from Moderna, a combo shot targeting that initial BA.1 omicron strain.
On Friday, the European Medicines Agency will consider whether to authorize the combination COVID-19 vaccine including BA.1 made by Pfizer-BioNTech and Moderna. Another version of the Pfizer-BioNTech vaccine incorporating the BA.5 subvariant of omicron is also under review by the EU regulator.

WHO: New Covid cases, deaths keep falling nearly everywhere

The number of new coronavirus cases and deaths reported globally continued to fall nearly everywhere in the world in what the World Health Organization described as a “welcome decline” at a media briefing on Wednesday.

The U.N. health agency said there were 4.5 million new COVID-19 cases reported last week, a 16% drop from the previous week

The number of new coronavirus cases and deaths reported globally continued to fall nearly everywhere in the world in what the World Health Organization described as a &ldquo;welcome decline&rdquo; at a media briefing on Wednesday.
The U.N. health agency said there were 4.5 million new COVID-19 cases reported last week, a 16% drop from the previous week. Deaths were also down by 13%, with about 13,500 fatalities. WHO said COVID-19 infections dropped everywhere in the world while deaths decreased everywhere except for Southeast Asia, where they climbed by 15% and in the Western Pacific, where they rose by 3%.
WHO Director-General Tedros Adhanom Ghebreyesus warned that with the coming onset of winter in the Northern Hemisphere and the possible emergence of a more dangerous new COVID-19 variant, experts expect to see a spike in hospitalisations and deaths. Tedros said vaccination rates, even in rich countries, were still too low, noting that 30% of health workers and 20% of older people remain unimmunised.
&ldquo;These vaccination gaps pose a risk to all of us,&rdquo; he said. &ldquo;Please get vaccinated if you are not and a booster if it's recommended that you have one.&rdquo; In the U.S., the Food and Drug Administration cleared its first update to COVID-19 vaccines on Wednesday, booster doses that target today's most common omicron strain. Authorities said shots could begin within days.
Until now, COVID-19 vaccines have targeted the original coronavirus strain, even as wildly different mutants emerged. The new U.S. boosters are combination, or &ldquo;bivalent,&rdquo; shots. They contain half that original vaccine recipe and half protection against the newest omicron versions, called BA.4 and BA.5, which are considered the most contagious yet.
Earlier this month, Britain decided it would offer adults 50 and over a different booster option from Moderna, a combo shot targeting that initial BA.1 omicron strain.
On Friday, the European Medicines Agency will consider whether to authorize the combination COVID-19 vaccine including BA.1 made by Pfizer-BioNTech and Moderna. Another version of the Pfizer-BioNTech vaccine incorporating the BA.5 subvariant of omicron is also under review by the EU regulator.
ALSO WATCH: <a href="https://www.editorji.com/world-news/saudi-woman-sentenced-to-45-years-in-prison-for-social-media-use-1661939224163">Saudi woman sentenced to 45 years in prison for social media use</a>

Reliance Life Sciences' application to conduct clinical trials of its two-dose Covid-19 vaccine got approval from the drug regulator on Thursday.

Reliance to manufacture Covid-19 vaccine; got drug regulator's approval

After its successful&nbsp;journey from oil to the&nbsp;internet&nbsp;to retail, India's biggest conglomerate Reliance has now stepped into manufacturing Covid-19 vaccines.

After its successful&nbsp;journey from oil to the&nbsp;internet&nbsp;to retail, India's biggest conglomerate Reliance has now stepped into manufacturing Covid-19 vaccines.
As per some reports, Reliance Life Sciences' application to conduct clinical trials of its two-dose&nbsp;Covid-19 vaccine got approval from the drug&nbsp;regulator on Thursday.
Phase 1 trials are usually conducted for 58 days, and once it is over Reliance could apply for Phase 2 and 3 trials.
Currently, there are six vaccines to have received emergency use authorisation. Serum Institute&rsquo;s Covishield, Bharat Biotech's Covaxin, Russia&rsquo;s Sputnik V, Moderna&rsquo;s, Johnson &amp; Johnson&rsquo;s, and Cadila&rsquo;s that was approved last week.

Reliance Life Sciences' to conduct clinical trials of its two-dose&nbsp;Covid-19 vaccine

After its successful&nbsp;journey from oil to the&nbsp;internet&nbsp;to retail, India's biggest conglomerate Reliance has now stepped into manufacturing Covid-19 vaccines.
As per some reports, Reliance Life Sciences' application to conduct clinical trials of its two-dose&nbsp;<a href="https://www.editorji.com/story/explained-should-you-mix-and-match-2-different-covid-19-vaccines-1627844423681" target="_blank">Covid-19 vaccine</a> got approval from the drug&nbsp;regulator on Thursday.
Phase 1 trials are usually conducted for 58 days, and once it is over <a href="https://www.editorji.com/story/jio-phone-next-pre-bookings-to-start-next-week-reports-1630047440915" target="_blank">Reliance</a> could apply for Phase 2 and 3 trials.
Currently, there are six vaccines to have received emergency use authorisation. Serum Institute&rsquo;s Covishield, Bharat Biotech's Covaxin, Russia&rsquo;s Sputnik V, Moderna&rsquo;s, Johnson &amp; Johnson&rsquo;s, and Cadila&rsquo;s that was approved last week.
Also Watch:&nbsp;<a href="https://www.editorji.com/story/meet-zycov-d-the-world-s-first-dna-covid-19-vaccine-everything-you-need-to-know-about-the-new-vaccine-1629658709134" target="_blank">Meet ZyCoV-D:&nbsp;The world&rsquo;s first DNA&nbsp;Covid-19&nbsp;vaccine; everything you need to know about the new vaccine</a>

&nbsp;The WHO and several experts have advised against taking jabs of two different Covid-19 vaccines it due to lack of studies and data but some countries have allowed it under exceptional circumstances.&nbsp;
&nbsp;

Explained: Should you mix and match 2 different Covid-19 vaccines?

&nbsp;The WHO and several experts have advised against taking jabs of two different Covid-19 vaccines it due to lack of studies and data but some countries have allowed it under exceptional circumstances.&nbsp;

Explained: Should you take jabs of 2 different Covid-19 vaccines?

The expert committee of India&rsquo;s&nbsp;Central Drugs Standard Control Organisation&nbsp;has recommended&nbsp;conducting a study on mixing doses of&nbsp;Covishield&nbsp;and&nbsp;Covaxin&nbsp;vaccines.&nbsp;

&nbsp;The WHO and several experts have advised against taking jabs of two different Covid-19 vaccines due to lack of studies and data but some countries have allowed it under exceptional circumstances.&nbsp;
&nbsp;

Moderna CEO on Thursday said new coronavirus strains are likely to emerge and countries will be required to get booster shots of the two-dose covid-19 vaccine as the southern hemisphere heads toward winter months from June. 
Speaking on a panel on CNBC, Stephane Bancel said, that over the next six months, as the Southern Hemisphere enters the fall and winter, we could see more variants of concern emerge, adding that booster shots will be needed as the virus is not going anywhere.
The comment comes a day after Moderna announced that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of COVID-19 first found in Brazil and South Africa.

New Covid strains will emerge in 6 months, will need booster shots: Moderna CEO

New Covid strains will emerge in 6 months, people will need booster shots, warns&nbsp;Moderna CEO

//&nbsp;Moderna&nbsp;CEO: virus here to stay,&nbsp;new strains likely in next 6 months // 'More Covid strains probable as Southern Hemisphere enters winter' // 'Countries will be required to get booster shots of the vaccine' //&nbsp;Moderna:&nbsp;3rd shot of its jab increases immunity against variants&nbsp;

Moderna CEO on Thursday said new coronavirus strains are likely to emerge and countries will be required to get booster shots of the two-dose covid-19 vaccine as the southern hemisphere heads toward winter months from June.
Speaking on a panel on CNBC, Stephane Bancel said, that over the next six months, as the Southern Hemisphere enters the fall and winter, we could see more variants of concern emerge, adding that booster shots will be needed as the virus is not going anywhere.
The comment comes a day after Moderna announced that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of COVID-19, first found in Brazil and South Africa.

vaccines

Categories